BIOMAT Database Logo BIOMAT Database Logo

Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype. 2000

N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
First Department of Pathology, Kochi Medical School, Nankoku City, Japan.

Vinculin is a cytoskeletal protein associated with membrane actin-filament-attachment sites of cell-cell and cell-matrix adherens-type junctions. In this article, we examine the expression of vinculin to elucidate its role in human renal neoplasms. We reviewed surgically resected specimens and selected available tissue from 79 renal tumors in 78 patients. There were 55 men and 23 women. Their mean age was 61 years and the mean size of the renal tumors was 6.1 cm. All renal tumors were examined by immunohistochemistry using a monoclonal antibody against vinculin. Overall, 17 (21.5%) renal tumor samples reacted with vinculin. The positive ratio in various types of renal tumors was as follows: conventional-type (clear cell), 0/54; papillary-type, 5/12; chromophobe-type, 5/5; sarcomatoid-type, 3/4; collecting duct carcinoma, 3/3; and oncocytoma, 1/1. The positive rate of conventional-type renal cell carcinomas (RCCs) is significantly different from that of other renal tumors (P < .01). Normal kidney, conventional, and papillary-type RCCs exhibited positive signals in Western blot analysis. These results suggest that vinculin may serve as a useful marker of renal neoplasms with collecting duct system phenotype such as chromophobe-type RCC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D007685 Kidney Tubules, Collecting Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla. Kidney Collecting Ducts,Kidney Collecting Duct,Collecting Duct, Kidney,Collecting Ducts, Kidney
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005314 Embryonic and Fetal Development Morphological and physiological development of EMBRYOS or FETUSES. Embryo and Fetal Development,Prenatal Programming,Programming, Prenatal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Neoplasms of the renal collecting system.
October 1987, Seminars in roentgenology,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Renal collecting system anatomy: its possible role in the effectiveness of renal stone treatment.
July 2001, Current opinion in urology,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Culturing of renal collecting duct epithelium as globular bodies.
January 1982, Cell and tissue research,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
[Collecting duct carcinoma associated with renal stones].
February 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Bradykinin induces formation of vesicle-like structures containing vinculin and PtdIns(4,5)P2 in renal papillary collecting duct cells.
November 2009, American journal of physiology. Renal physiology,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Electrolyte transport in the renal collecting duct and its regulation by the renin-angiotensin-aldosterone system.
January 2019, Clinical science (London, England : 1979),
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Renal collecting duct carcinoma in a dog.
July 2008, Veterinary pathology,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Collecting duct carcinoma: a rare renal tumor.
July 2012, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.
January 2010, Archives of pathology & laboratory medicine,
N Kuroda, and K Naruse, and E Miyazaki, and Y Hayashi, and C Yoshikawa, and S Ashida, and T Moriki, and Y Yamasaki, and S Numoto, and Y Yamamoto, and I Yamasaki, and M Hiroi, and T Shuin, and H Enzan
[Physiology of renal papillary collecting duct].
July 1986, Nihon Jinzo Gakkai shi,
Copied contents to your clipboard!